Stryker to Acquire Inari Medical for ~$4.9B
Shots:
- Stryker has signed a definitive agreement to initiate a tender offer for acquiring all the issued & outstanding shares of Inari Medical for $80 per share in cash, making it a total value of ~$4.9B
- Upon completion, Stryker will acquire remaining shares in a second-step merger at the same price. The deal is expected to close by Q1’25, pending customary conditions
- The acquisition adds Inari's mechanical thrombectomy solutions for deep vein thrombosis & pulmonary embolism to Stryker’s neurovascular business, bolstering its position in the peripheral vascular segment, mainly in venous thromboembolism (VTE)
Ref: Stryker| Image: Inari Medical
Related News: Stryker Signs a Definitive Agreement to Acquire Vocera Communications for ~$3.09B
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.
